NCT04649632已完成不适用
Relation Between Dose and Time to Reinjection of Botulinum Toxin-A in Patient With Poststroke Spasticity From a Real-world Healthcare Insurance Database.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Ipsen
- 入组人数
- 451
- 试验地点
- 1
- 主要终点
- Dosing of botulinum toxin-A in daily practice in relation to time to next injection
研究概览
简要总结
Determining the mean/median time between botulinum toxin-A injection within the treatment of patients with spasticity after stroke in relation to the botulinum toxin dose from a healthcare insurance database in the Netherlands.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 25 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •A patient will be included if he has a diagnosis stroke within the rehabilitation setting and has received at least two injections of botulinum toxin-A: Dysport or Botox
排除标准
- •A patient will be excluded if he has been only treated with Xeomin
结局指标
主要结局
Dosing of botulinum toxin-A in daily practice in relation to time to next injection
时间窗: From baseline up to end of data collection (January 2012 up to December 2016)
Mean time to next injection per brand
时间窗: From baseline up to end of data collection (January 2012 up to December 2016)
Median time to next injection per brand
时间窗: From baseline up to end of data collection (January 2012 up to December 2016)
次要结局
- Time interval between 2 injections of the same brand(From baseline up to end of data collection (January 2012 up to December 2016))
- Average cost per year per brand per patient(From baseline up to end of data collection (January 2012 up to December 2016))
- Exploring factors like age, gender, time since diagnosis stroke that influence dosing and time between botulinum toxin-A treatments(From baseline up to end of data collection (January 2012 up to December 2016))
研究者
研究点 (1)
Loading locations...
相似试验
终止
2 期
Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive BladderOveractive BladderNCT00578097Ipsen81
撤回
不适用
Botox for Gummy SmileGingival ExposureNCT03284047Northwestern University
招募中
不适用
Exoskeleton Robotic Assisted Gait Training in Spastic Stroke Post Botulinum Toxin a InjectionSpastic GaitSpasticNCT06070987Chang Gung Memorial Hospital36
尚未招募
不适用
Botulinum toxin type A injections in stiff knee gait.In the Netherlands live about 18.000 Cerebro Vascular Accident (CVA)-patients which discover problems with walking caused by insufficient footclearance. Causes of problems with the footclearance during the swing phase of gait are a combination of diminished dorsal flexion of the ankle, knee flexion and hip flexion. A diminished knee flexion during swing is defined a stiff knee gait. A stiff knee gait is often caused by an overactivity of the m. rectus femoris. Keywords: stroke, stiff knee gaitNL-OMON29171Roessingh Research and DevelopmentRoessinghsbleekweg 337577 AH Enschede26
已完成
不适用
Observational Study of Botulinum Toxin Type A in Patients With Urinary Incontinence Associated With Overactive BladderUrinary Bladder, OveractiveUrinary Bladder, NeurogenicNCT02673047Allergan474